front-line therapy with nivolumab and salvage nivolumab ipilimumab in patients with advanced rcc
Published 4 years ago • 217 plays • Length 8:26Download video MP4
Download video MP3
Similar videos
-
5:44
hcrn-gu16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced rcc
-
6:16
treatment-free survival results of nivolumab and salvage nivolumab ipilimumab for accrcc
-
9:09
nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced rcc
-
1:52
hcrn gu16-260: nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with adv...
-
6:01
metastatic rcc: using frontline ipilimumab/nivolumab
-
5:10
checkmate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for rcc
-
1:34
fda approval of frontline nivolumab/ipilimumab combo in rcc
-
2:09
comparing afami-cel with existing treatments in synovial sarcoma
-
5:19
fraction-rcc: evaluating nivolumab plus ipilimumab in patients with treatment-refractory advance...
-
1:55
investigating responses to nivolumab and ipilimumab in advanced rcc
-
5:52
nivolumab and salvage nivolumab plus ipilimumab for arcc
-
2:08
nivolumab with ipilimumab for mrcc
-
1:49
cosmic-313: cabozantinib with nivolumab and ipilimumab in untreated arcc
-
4:50
ipilimumab/nivolumab in first-line mrcc
-
5:42
asco: nivolumab followed by salvage ipilimumab plus nivolumab for patients with advanced rcc
-
2:54
combining nivolumab and ipilimumab in patients with resected stage iv melanoma
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
0:52
dr. mckay on fda approval of nivolumab/ipilimumab in frontline rcc
-
0:51
dr. pal on the frontline approval of nivolumab and ipilimumab in mrcc